COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Sarzi‐Puttini, Piercarlo; Giorgi, Valeria; Sirotti, Silvia; Marotto, Daniela; Ardizzone, Sandro; Rizzardini, Giuliano; Antinori, Spinello; Galli, Massimo

doi:10.55563/clinexprheumatol/xcdary

Public

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Published in Clinical and Experimental Rheumatology • Mar 26, 2020

Authors:

Piercarlo Sarzi‐Puttini

Valeria Giorgi

Silvia Sirotti

Abstract

A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December 2019, and spread so rapidly that more than 200,000 cases have so far been reported worldwide; on January 30, 2020, the WHO declared it the sixth public health emergency of international concern. The two previously ...

Subject

Medicine

Pandemic

Middle East respiratory syndrome

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!